Medical Developments International Past Earnings Performance
Past criteria checks 0/6
Medical Developments International's earnings have been declining at an average annual rate of -47.3%, while the Pharmaceuticals industry saw earnings declining at 0.2% annually. Revenues have been growing at an average rate of 9% per year.
Key information
-47.3%
Earnings growth rate
-44.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | 9.0% |
| Return on equity | -25.4% |
| Net Margin | -57.3% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Medical Developments International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 34 | -19 | 43 | 0 |
| 30 Sep 23 | 33 | -12 | 39 | 0 |
| 30 Jun 23 | 32 | -6 | 36 | 0 |
| 31 Mar 23 | 29 | -4 | 32 | 0 |
| 31 Dec 22 | 26 | -2 | 28 | 0 |
| 30 Sep 22 | 24 | -7 | 26 | 0 |
| 30 Jun 22 | 22 | -12 | 25 | 0 |
| 31 Mar 22 | 22 | -16 | 26 | 0 |
| 31 Dec 21 | 22 | -19 | 27 | 0 |
| 30 Sep 21 | 24 | -16 | 24 | 0 |
| 30 Jun 21 | 25 | -13 | 20 | 0 |
| 31 Mar 21 | 25 | -7 | 16 | 0 |
| 31 Dec 20 | 24 | -1 | 11 | 0 |
| 30 Sep 20 | 23 | 0 | 11 | 0 |
| 30 Jun 20 | 23 | 0 | 11 | 0 |
| 31 Mar 20 | 22 | 1 | 10 | 0 |
| 31 Dec 19 | 22 | 1 | 10 | 0 |
| 30 Sep 19 | 22 | 1 | 10 | 0 |
| 30 Jun 19 | 21 | 1 | 10 | 0 |
| 31 Mar 19 | 20 | 1 | 10 | 0 |
| 31 Dec 18 | 19 | 0 | 10 | 0 |
| 30 Sep 18 | 18 | 0 | 10 | 0 |
| 30 Jun 18 | 17 | 0 | 9 | 0 |
| 31 Mar 18 | 18 | 1 | 9 | 0 |
| 31 Dec 17 | 18 | 2 | 8 | 0 |
| 30 Sep 17 | 18 | 2 | 8 | 0 |
| 30 Jun 17 | 18 | 2 | 8 | 0 |
| 31 Mar 17 | 18 | 2 | 8 | 0 |
| 31 Dec 16 | 18 | 2 | 7 | 0 |
| 30 Sep 16 | 17 | 2 | 7 | 0 |
| 30 Jun 16 | 15 | 2 | 7 | 0 |
| 31 Mar 16 | 14 | 1 | 6 | 0 |
| 31 Dec 15 | 12 | 1 | 5 | 0 |
| 30 Sep 15 | 12 | 1 | 5 | 0 |
| 30 Jun 15 | 12 | 2 | 4 | 0 |
| 31 Mar 15 | 11 | 1 | 4 | 0 |
| 31 Dec 14 | 10 | 1 | 4 | 0 |
| 30 Sep 14 | 10 | 1 | 4 | 0 |
| 30 Jun 14 | 9 | 1 | 4 | 0 |
| 31 Mar 14 | 10 | 1 | 4 | 0 |
| 31 Dec 13 | 10 | 1 | 4 | 0 |
| 30 Sep 13 | 11 | 2 | 4 | 0 |
| 30 Jun 13 | 12 | 2 | 4 | 0 |
Quality Earnings: MDDV.F is currently unprofitable.
Growing Profit Margin: MDDV.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MDDV.F is unprofitable, and losses have increased over the past 5 years at a rate of 47.3% per year.
Accelerating Growth: Unable to compare MDDV.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MDDV.F is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (19.9%).
Return on Equity
High ROE: MDDV.F has a negative Return on Equity (-25.38%), as it is currently unprofitable.